Sage Journals: Discover world-class research

Abstract

Background:

Cardiogenic shock due to severe aortic regurgitation in patients with left ventricle assist devices is a life threatening condition. Here, we consider transcatheter aortic valve implantation as a treatment option.

Methods and results:

A patient with a left ventricle assist device was presented to us with cardiogenic shock due to severe aortic regurgitation. We successfully implanted a transcatheter aortic valve in emergency setting. The patient recovered and underwent cardiac transplantation three months afterwards. We performed a systematic literature review and identified 10 cases of patients with a left ventricle assist device undergoing transcatheter aortic valve implantation. In these cases, there was no procedural related mortality reported. In four (40%) patients, transcatheter aortic valve implantation resulted in significant paravalvular aortic regurgitation. In two of these cases it was due to migration of the valve towards the left ventricle.

Conclusions:

Our case report and review of literature suggests that transcatheter aortic valve implantation is a feasible and lifesaving treatment option for left ventricle assist device patients presenting with severe aortic regurgitation.

Keywords

Aortic regurgitation transcatheter aortic valve implantations left ventricle assist device

Get full access to this article

View all access options for this article.

References

D’Ancona

Pasic

Buz

et al . TAVI for pure aortic valve insufficiency in a patient with a left ventricular assist device. Ann Thorac Surg 2012; 93: e89–e91

Santini

Forni

Dandale

et al . First successful management of aortic valve insufficiency associated with Heartmate II left ventricular assist device support by transfemoral Corevalve implantation: The Columbus egg? JACC Cardiovasc Interv 2012; 5: 114–115.

Lavee

Segev

Preisman

et al . First-in-man transfemoral transcatheter aortic valve implantation for severe aortic regurgitation in a patient with left ventricular assist device. J Heart Lung Transplant 2013; 32: S187–S188.

Ong

B-H

Chiam

PTL

Sim

DKL

et al . Post-implantation transcatheter aortic valve migration in a left ventricular assist device patient with severe aortic insufficiency. Eur Heart J 2014; 35: 1616.

Khan

Koerner

Pae

et al . Successful percutaneous transcatheter aortic valve replacement in multi-organ failure due to aortic bioprosthesis regurgitation in a patient with continuous-flow LVAD. J Heart Lung Transplant 2013; 32: 659–663.

Wilson

Goldraich

Parry

et al . Cardiac arrest secondary to sudden LVAD failure in the setting of aortic valve fusion successfully managed with emergent transcatheter aortic valve replacement. Int J Cardiol 2014; 171: e40–e41.

Krause

Metz

Bushnaq

Direct aortic transcatheter aortic valve implantation for pure aortic valve regurgitation after implantation of a left ventricular assist device. J Thorac Cardiovasc Surg 2014; 147: e38–e39.

Ribichini

Faggian

Pessarini

et al . Bail-out transcatheter aortic valve implantation to reduce severe acute aortic regurgitation in a failing homograft secondary to HeartMate II ventricular assistance device. Cardiovasc Revasc Med 2014; 15: 295–297.

Vavalle

Kiefer

Milano

et al . Transcatheter aortic valve replacement performed via left ventricular assist device inflow cannula. Circ Heart Fail 2014; 7: 544–546.

10.

Parry

Rao

Butany

et al . Transcatheter aortic valve implantation and left ventricular assist device: A word of caution. Ann Thorac Surg 2014; 97: e41–e42.

11.

Rajagopal

Daneshmand

Patel

et al . Natural history and clinical effect of aortic valve regurgitation after left ventricular assist device implantation. J Thorac Cardiovasc Surg 2013; 145: 1373–1379.

12.

Cowger

Pagani

Haft

et al . The development of aortic insufficiency in left ventricular assist device-supported patients. Circ Heart Fail 2010; 3: 668–674.

13.

Aggarwal

Raghuvir

Eryazici

et al . The development of aortic insufficiency in continuous-flow left ventricular assist device-supported patients. Ann Thorac Surg 2013; 95: 493–949.

14.

Rose

Park

Bank

et al . Partial aortic valve fusion induced by left ventricular assist device. Ann Thorac Surg 2000; 70: 1270–1274.

15.

Connelly

Abrams

Klima

et al . Acquired commissural fusion of aortic valves in patients with left ventricular assist devices. J Heart Lung Transplant 2003; 22: 1291–1295.

16.

Letsou

Connelly

Delgado

et al . Is native aortic valve commissural fusions in patients with long-term left ventricular assist devices associated with clinically important aortic insufficiency? J Heart Lung Transplant 2006; 25: 395–399.

17.

John

Mantz

Eckman

et al . Aortic valve pathophysiology during left ventricular assist device support J Heart Lung Transplant 2010; 29: 1321–1329.

18.

Russo

Freed

Jeevanandam

et al . Percutaneous transcatheter closure of the aortic valve to treat cardiogenic shock in a left ventricular assist device patient with severe aortic insufficiency. Ann Thorac Surg 2012; 94: 985–988.

19.

Parikh

Mehrotra

Russo

et al . Percutaneous transcatheter aortic valve closure successfully treats left ventricular assist device-associated aortic insufficiency and improves cardiac hemodynamics. JACC Cardiovasc Interv 2013; 6: 84–89.

20.

Freed

Paul

Bhave

et al . Percutaneous transcatheter closure of the native aortic valve to treat de novo aortic insufficiency after implantation of a left ventricular assist device. JACC Cardiovasc Interv 2013; 6: 84–89.

21.

LIung

Laouénan

Himbert

et al .; FRANCE 2 Investigators. Predictive factors of early mortality after transcatheter aortic valve implantation: Individual risk assessment using a simple score. Heart 2014; 100: 1016–1023.